SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-174175
Filing Date
2019-06-17
Accepted
2019-06-17 06:08:02
Documents
8
Period of Report
2019-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d766838d6k.htm 6-K 66808
2 GRAPHIC g766838g26h36.jpg GRAPHIC 52872
3 GRAPHIC g766838g39k08.jpg GRAPHIC 29905
4 GRAPHIC g766838g42i73.jpg GRAPHIC 39907
5 GRAPHIC g766838g59h85.jpg GRAPHIC 51602
6 GRAPHIC g766838g80y23.jpg GRAPHIC 62769
7 GRAPHIC g766838g99i97.jpg GRAPHIC 63881
8 GRAPHIC g766838n1.jpg GRAPHIC 2899
  Complete submission text file 0001193125-19-174175.txt   487221
Mailing Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
Business Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 19900322
SIC: 2834 Pharmaceutical Preparations